A detailed history of Hexagon Capital Partners LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 1,331 shares of ACAD stock, worth $22,853. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,331
Previous 1,186 12.23%
Holding current value
$22,853
Previous $19,000 5.26%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$15.14 - $19.14 $2,195 - $2,775
145 Added 12.23%
1,331 $20,000
Q2 2024

Jul 12, 2024

BUY
$14.62 - $18.42 $12,456 - $15,693
852 Added 255.09%
1,186 $19,000
Q1 2024

Apr 18, 2024

BUY
$17.79 - $30.86 $5,337 - $9,258
300 Added 882.35%
334 $6,000
Q4 2023

Feb 05, 2024

BUY
$20.78 - $31.77 $706 - $1,080
34 New
34 $1,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.78B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.